The ‘last mile’ from drug substance to a patient-ready drug product is where many development programs stall, especially for innovative medicines and noval delivery technologies. Success increasingly depends on a combination of experience with new delivery and formulation technologies. Join this 15-minute webinar to hear how Asymchem solves this challenge through Center of Drug Delivery and Formulation (CDDF). Discover how CDDF—working alongside drug substance, regulatory affairs, and GMP manufacturing teams—turns even the most demanding formulation requirements into a workable solution.

• Solution-driven formulation support across most dosage forms, from oral solids, sterile injectables, and lyophilized products to complex formulations such as, liposomes, LNPs, microsuspensions, nanosuspensions, and oral peptides.
• Tried-and-tested end-to-end formulation capabilities spanning formulation design, GMP manufacturing, and regulatory compliance, supported by continuous method and process development.
• One integrated drug substance, regulatory, and manufacturing team accelerates clinical entry and delivers solutions for the most challenging formulation programs.

Sponsored by:

Speaker:



Dr. Junzhang Chen
Chief Scientist of Center of Drug Delivery and Formulation
Asymchem Life Science (Tianjin) Co., Ltd.